IT1271434B - Composizione farmaceutica avente attivita' antiasmatica - Google Patents

Composizione farmaceutica avente attivita' antiasmatica

Info

Publication number
IT1271434B
IT1271434B ITMI930453A ITMI930453A IT1271434B IT 1271434 B IT1271434 B IT 1271434B IT MI930453 A ITMI930453 A IT MI930453A IT MI930453 A ITMI930453 A IT MI930453A IT 1271434 B IT1271434 B IT 1271434B
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
asthmatic activity
methoxy
active ingredient
asthmatic
Prior art date
Application number
ITMI930453A
Other languages
English (en)
Inventor
Luigi Allegra
Negro Roberto Dal
Original Assignee
Bartel Due S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bartel Due S R L filed Critical Bartel Due S R L
Priority to ITMI930453A priority Critical patent/IT1271434B/it
Publication of ITMI930453A0 publication Critical patent/ITMI930453A0/it
Publication of ITMI930453A1 publication Critical patent/ITMI930453A1/it
Application granted granted Critical
Publication of IT1271434B publication Critical patent/IT1271434B/it

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Viene descritto l'uso dell'omeprazolo o 5-metossi-2-??(4-metossi-3,5-dimetil-2-piridinil)metil]sulfinil]-1H-benz imidazolo come principio attivo nella cura dell'asma bronchiale e vengono descritte le composizioni farmaceutiche ad attività antiasmatica le quali contengono quale principio attivo tale composto.
ITMI930453A 1993-03-10 1993-03-10 Composizione farmaceutica avente attivita' antiasmatica IT1271434B (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI930453A IT1271434B (it) 1993-03-10 1993-03-10 Composizione farmaceutica avente attivita' antiasmatica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930453A IT1271434B (it) 1993-03-10 1993-03-10 Composizione farmaceutica avente attivita' antiasmatica

Publications (3)

Publication Number Publication Date
ITMI930453A0 ITMI930453A0 (it) 1993-03-10
ITMI930453A1 ITMI930453A1 (it) 1994-09-10
IT1271434B true IT1271434B (it) 1997-05-28

Family

ID=11365300

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI930453A IT1271434B (it) 1993-03-10 1993-03-10 Composizione farmaceutica avente attivita' antiasmatica

Country Status (1)

Country Link
IT (1) IT1271434B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075926A1 (en) * 2002-03-14 2003-09-18 Altana Pharma Ag Use of proton pump inhibitors for the treatment of airway disorders

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075926A1 (en) * 2002-03-14 2003-09-18 Altana Pharma Ag Use of proton pump inhibitors for the treatment of airway disorders

Also Published As

Publication number Publication date
ITMI930453A0 (it) 1993-03-10
ITMI930453A1 (it) 1994-09-10

Similar Documents

Publication Publication Date Title
MY111737A (en) Use of omeprazole as an antimicrobial agent.
CA2274076A1 (en) Crystalline form of s-omeprazole
BR9902268A (pt) Formulações de ziprasidona.
AR013350A1 (es) Sal de sodio de omeprazol forma b, proceso para su preparacion, formulacion farmaceutica, y uso de dicha sal para la fabricacion de medicamentos.
TR199902934T2 (xx) S-Omeprazol�n yeni yap�s�.
MY125399A (en) Benzimidazole compound crystal.
WO2001062737A3 (en) Amino pyrazole derivatives useful for the treatment of obesity and other disorders
CA2357744A1 (en) Potassium salt of (s)-omeprazole
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
AU2855399A (en) Vascularization inhibitors
PH27257A (en) Therapeutically active chloro substituted benzimidazole
ZA989999B (en) New process for the preparation of 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)1H-benzimidazole
BR0209103A (pt) Omeprazol forma c, processo para preparação e uso do mesmo e formulação farmacêutica
NO971997D0 (no) Bruk av immunmodulerende midler
IT1271434B (it) Composizione farmaceutica avente attivita' antiasmatica
DK0544760T3 (da) Farmaceutiske præparater indeholdende 5-difluormethoxy-2- (3,4-dimethoxy-2-pyridyl)methylsulfinyl benzimidazol og at anti-helicobactermiddel til behandling af gastrointestinale lidelser
DE69929635D1 (de) Neue pharmazeutische zusammenstellung und deren herstellungsprozess
YU14503A (sh) Novi farmaceutski preparati
AU4930300A (en) Use of antibodies identifying the interleukin-2 receptor for preventing and/or treating hiv infections
WO2002100346A3 (en) (r, r'),(r',s')-amphetaminil, compositions and uses thereof
WO2002100342A3 (en) (s, s'), (s, r')-amphetaminil, compositions and uses thereof
AU2002335332A1 (en) Composition containing fine particles for supporting biologically active substance thereon or having the same supported thereon and method for preparing these

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970324